[ad_1]
Some staff members at the Food and Drug Administration are considering leaving their positions due to concerns over Robert F. Kennedy Jr. potentially being appointed to a health role in the upcoming Trump administration. Anxiety stems from uncertainty about what changes Kennedy may bring to the agency and how they could impact employees. Despite turnover being typical with a new administration, employees are particularly wary this time due to Kennedy’s potential influence. The FDA has not responded to inquiries about staff considering leaving, but it’s reported that dozens may be contemplating their options. The uncertainty surrounding Kennedy’s role and the potential impact on the agency’s operation has some employees feeling apprehensive about their future.
FDA Commissioner Robert Califf expressed disappointment with the election results and uncertainty about what lies ahead for the agency. The possibility of a “mass exodus” of employees is uncertain, with many waiting to see how the situation unfolds. There are concerns about potential new restrictions on post-employment, adding to the uncertainty for staff members. Some are considering retirement as a possible option, as more than 18,000 employees work for the FDA. It’s possible that Kennedy may not have significant influence over the agency’s functioning or may be put in a role that limits his impact. Despite the uncertainty, some employees are taking a wait-and-see approach and monitoring the situation to make informed decisions about their future at the FDA.
Photo credit
www.nbcnews.com
